Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00477334 · ClinicalTrials.gov registry record · Phase 4
Patient-initiated Episodic Treatment of Recurrent Genital Herpes in Black Patients
A Phase 4 study, sponsored by Novartis.
- Completed
- Registry status
- Phase 4
- Development phase
- 463
- Enrollment target
NCT00477334 is a Phase 4 study that has completed, run by Novartis. The registered enrollment target is 463 participants.
The verdict
NCT00477334, a Phase 4 study, has completed, sponsored by Novartis.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 463 participants
- Enrollment target
Study Summary
This study will evaluate the safety and efficacy of single-day famciclovir episodic treatment in Black patients with recurrent genital herpes
Interventions
- DRUG Placebo
- DRUG Famciclovir
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 463 participants |
| Start Date | 2007-06 |
| Est. Completion | 2009-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00477334
The ClinicalTrials.gov registry entry for NCT00477334 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 463 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Novartis, which has 265 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00477334 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00477334 about?
NCT00477334 is a clinical study titled "Patient-initiated Episodic Treatment of Recurrent Genital Herpes in Black Patients". This study will evaluate the safety and efficacy of single-day famciclovir episodic treatment in Black patients with recurrent genital herpes
What is the current status of trial NCT00477334?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 463 participants. The study started on 2007-06. Estimated completion is 2009-03.
What interventions are being tested in trial NCT00477334?
The interventions under investigation include: Placebo (DRUG), Famciclovir (DRUG).
Who is sponsoring clinical trial NCT00477334?
This trial is sponsored by Novartis, which has 265 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.